F4 FundFund
TeamPortfolioRaiseChampionsEssays
Sign in
Investment ThesisInvestment TeamF4 Research BriefSelected PortfolioRecent UpdatesFrequent co-investorsSimilar Firms
Warm Fund
#57 · Emerging 100 · 2026

Cantos

cantos.vc · San Francisco, California

“We invest in people who will transform the physical world. Near frontier technology solving climate change, disease, armed conflict, poverty, and existential risks.”

$400K – $1.5M
Check Size
Leads
Lead Tendency
$120M
AUM
~1 Month
Timeline
01Investment Thesis

Technical founders building capital-intensive, long-horizon companies.

Exclusion Criteria

No consumer-only applications, non-technical founders in hardware/biotech, software-only solutions to physical-world problems, teams without domain expertise

02Investment Team
IR
Ian Rountree
Founder & General Partner
GG
Grant Gregory
Partner
AK
Amee Kapadia
Principal
SG
Sofia Garcia
CFO
NE
Natalie Estrella
Advisor
AU
Achal Upadhyaya
Advisor
BU
Bob Urberger
Advisor
AK
Anand Kapadia
Advisor
03F4 Research Brief

Cantos Ventures Research

Investment Thesis

Cantos Ventures is a specialized venture capital firm focused on what they call "near frontier" technology—deeply technical, capital-intensive companies that are transforming the physical world. Rather than confining innovation to software and digital spaces, Cantos believes the most impactful breakthroughs will come from founders solving critical infrastructure, climate, aerospace, biotech, and advanced manufacturing challenges. They describe their philosophy as investing in "people who will transform the physical world" and backing "relentless world-changers from day one." The firm explicitly rejects the term "deep tech" as reductive, instead positioning their investments as solutions to humanity's biggest problems: climate change, disease mitigation, armed conflict prevention, poverty alleviation, and existential risks.

Sector and Industry Focus

Cantos has deep expertise across multiple adjacent sectors:

Core Focus Areas:

  • Climate & Energy: Carbon capture, renewable energy manufacturing, sustainable materials, decarbonization (Arbor, Limelight Steel, Cache Energy, Furno Materials, Remedy, Twelve)
  • Aerospace & Defense: Advanced satellite systems, hypersonic propulsion, unmanned defense systems (Astranis, Venus Aerospace, Neros, Castelion, Skyryse)
  • Biotechnology: Therapeutics, synthetic biology, gene therapy, diagnostic innovations (Faeth, Character Bio, Sixfold Bio, Nabla Bio, Modulo, Glyphic Bio, Solugen, Curie Co)
  • Advanced Manufacturing & Robotics: Automation, intelligent construction, electric vehicle ecosystems, precision manufacturing (Dusty Robotics, Intramotev, Salient Motion, Fleetzero)
  • Quantum Computing & Hardware: Next-generation computation infrastructure (Atom Computing, Catalog DNA)
  • Food & Agriculture Tech: Sustainable food systems, aquaculture automation (Shinkei, Mission Barns, SoloPulse)
  • Infrastructure & Materials: Advanced materials, decarbonized industrial processes (Limelight Steel, Furno Materials, Remedy, Bedrock Energy)

Stage Focus

Cantos is explicitly positioned as a first-money-in partner for early-stage founders:

  • Pre-seed: Ideal stage for their investment thesis; supporting founders at the prototype phase
  • Seed: Primary investment stage with product validation
  • Rare Series A follow-ons with existing portfolio companies

The fund actively seeks to be the first institutional investor in deeply technical ventures, providing strategic support beyond capital.

Investment Check Size

Range: $400K - $1.5M

  • Pre-seed tickets: Typically $400K-$750K
  • Seed tickets: Typically $750K-$1.5M
  • Target ownership: 15-25% in pre-seed, 10-20% in seed rounds

This sizing reflects their focus on early-stage capital allocation for technical infrastructure and manufacturing ventures.

Recent Activity and Portfolio Growth

As of October 2025, Cantos has invested in 71 portfolio companies with 5 new investments in the last 12 months. The firm is actively deploying from its $120M+ under management (Fund III: $50M closed in 2022).

Fund Status

Fund III ($50M) announced September 2022, now in active deployment phase (Q4 2025). The fund maintains a 3-5 year deployment strategy, typical for deep tech venture firms. With 71 total portfolio companies and recent activity, Cantos appears to be in steady deployment mode with strong market momentum behind physical-world infrastructure innovation.

Investment Approach & Decision Process

First Money In Philosophy:

  • Prefer to lead pre-seed and seed rounds
  • Provide strategic partnership beyond capital (technical expertise, network introductions)
  • Support founders in navigating regulatory and scale-up challenges
  • Active engagement: board seats or advisory positions in most portfolio companies

Decision Timeline: Typically 4-6 weeks from initial meeting to term sheet for strong technical founders, faster for technical co-founders with relevant domain expertise

Warm Introduction Preference: Strong preference for warm introductions through existing LPs, technical advisors, or portfolio founders. Direct outreach possible for exceptionally technical founding teams with relevant experience.

Due Diligence Focus:

  • Technical credibility of founding team
  • Depth of domain expertise and relevant experience
  • Regulatory and technical feasibility assessment
  • Market timing and infrastructure readiness
  • Long-term mission alignment with physical-world impact

Team and Leadership

Ian Rountree (Founder & General Partner) is the visionary behind Cantos, founding the firm to focus on near-frontier startups. He drives the first-check investor philosophy and maintains deep expertise in deep tech and near-frontier ventures. He is an active blogger and podcaster on hard tech trends.

Grant Gregory (Partner) recently joined the firm and brings additional operational and domain expertise to investment decisions and portfolio support.

Amee Kapadia (Principal) leads investment responsibility for portfolio support and sourcing activities.

Sofia Garcia (CFO) manages fund operations and financial management.

The advisory team—Natalie Estrella, Achal Upadhyaya, Bob Urberger, and Anand Kapadia—provides domain expertise spanning aerospace, energy, biotech, and advanced manufacturing.

Geographic Focus

Primary Markets:

  • San Francisco Bay Area: HQ, dense founder network, hardware talent concentration
  • US Nationwide: Open to strong technical founders across US regions
  • International: Selective investments in Europe and Israel for specialized deep tech (especially biotech)

Content and Thought Leadership

Cantos actively publishes through multiple channels including Medium, Substack (cantosventures.substack.com), and a podcast called "Near Frontier." The firm features portfolio deep-dives, industry trends analysis, and founder interviews. They maintain active hiring and demonstrate visible commitment to team building.

Portfolio Company Characteristics

Cantos' success pattern shows:

  • Technically ambitious founders (often with PhDs or deep domain experience)
  • Capital-intensive, hardware-forward or biotech solutions
  • 5-10+ year time horizons to commercialization
  • Regulatory complexity often as moat
  • Potential for massive impact across millions of lives

The 71-company portfolio spans energy, aerospace, biotech, robotics, and materials science, with a mix of pre-revenue science-stage to Series A transitioning companies. Strong focus on founders with relevant industry experience and concentration in climate and deeptech infrastructure.

Founder Preferences

What They Love:

  • Deeply technical founding teams (PhDs, industry veterans)
  • Founders solving existential or critical infrastructure problems
  • Teams with relevant domain experience
  • Patient founders comfortable with long timelines
  • Mission-driven founders vs. quick exit focused

What They Avoid:

  • Non-technical founders in hardware/biotech spaces
  • Consumer applications in core markets
  • Software-only solutions to physical-world problems
  • Companies requiring breakthrough science before customer traction
  • Teams without relevant domain expertise

Fund Performance and Track Record

  • Established 2015 by Ian Rountree
  • $120M+ under management across multiple funds
  • Fund III ($50M) closed 2022, in active deployment
  • 71 portfolio companies demonstrating strong deployment pace
  • Multiple exits and follow-on funding demonstrating investor confidence

Key Differentiators

  1. True pre-seed specialist - Most VCs avoid this stage; Cantos embraces it
  2. Founder-centric: Patient capital, operational support, network effects
  3. Technical depth: Partners deeply understand underlying science and engineering
  4. Physical world focus: Concentration in sectors where code alone doesn't solve problems
  5. Thought leadership: Active intellectual contribution to deep tech conversation

Cantos represents a focused thesis on transformation through deeply technical, capital-intensive innovation in the physical world. They excel at identifying and supporting founders tackling humanity's most difficult problems.

04Selected Portfolio
Aerospace & Defense
Neros·Skyryse·Astranis·Venus Aerospace·Apex Space·Salient Motion·Castelion
Biotech & Life Sciences
Aizon·Character Bio·Debut Biotech·Faaeth Therapeutics·Glyphic Biotechnologies·Modulo·Nabla Bio·Phenomic·Pow.Bio·Prellis·Sixfold Bio·Spaero Bio
Climate & Sustainability
Remedy Scientific·Twelve·Cache Energy·Vital Lyfe
E-commerce & Marketplaces
Earth AI·Catalog
Energy & Power
Radiant Nuclear·Fleetzero·Arbor·Bedrock Energy
Food & Beverage
Shinkei·Curie Co·Mission Barns
Healthcare & Digital Health
MoldCo
Logistics & Supply Chain
Intramotev
Manufacturing & Industrial
Solugen·Limelight Steel·Furno Materials·The Lumber Manufactory
Media & Entertainment
SoloPulse
Robotics & Automation
Dusty Robotics
Semiconductors & Hardware
Atom Computing
Travel & Hospitality
Pilgrim
Open the full portfolio→
05Recent Updates

Fresh signals from public announcements, essays, and portfolio activity.

See full activity (12) →
Published a thesis essay on why nuclear microreactors represent the future of portable energy infrastructure and power distribution.
ESSAY·medium.com
Added recently
Portfolio company Radiant Nuclear achieved unicorn status and raised $300M+ in Series D funding for portable nuclear microreactor production.
MILESTONE·radiantnuclear.com
DEC 2025
Participated in Castelion's $350M Series B to accelerate mass production of U.S. hypersonic weapons systems.
INVESTMENT·castelion.com
DEC 2025
Co-led $8M seed round for MoldCo's virtual clinic for mold toxicity testing and treatment.
INVESTMENT·citybiz.co+1
SEP 2025
Ian Rountree reflects on Cantos' portfolio performance, finding that the depth of technology has little correlation with success. Argues that having some 3D technology as a fulcrum matters, but application relative to the industry/problem is what drives outcomes.
ESSAY·medium.com
AUG 28, 2025
06Frequent co-investors
HV
Harpoon Ventures
Both backed 5 of the same companies
Astranis, Solugen, MoldCo, Salient Motion,
+1 moreGlyphic Biotechnologies
I
Interlagos
Both backed 5 of the same companies
Neros, Castelion, Shinkei, Vital Lyfe,
+1 moreApex Space
RC
Refactor Capital
Both backed 4 of the same companies
Remedy Scientific, Astranis, Solugen, Pilgrim
AV
Aera VC
Both backed 3 of the same companies
Solugen, Twelve, Intramotev
FY
Fifty Years
Both backed 3 of the same companies
Astranis, Solugen, Atom Computing
Find the investors for your round→
07Similar Firms
DC
Divergent Capital
$250K – $1M · Pre-Seed · Seed
→
RC
Refactor Capital
$1M – $2M · Pre-Seed · Seed
→
HV
Humba Ventures
$250K – $1M · Pre-Seed · Seed
→
FV
Future Ventures
$500K – $10M · Pre-Seed · Seed
→
AV
Aera VC
$500K – $20M · Pre-Seed · Seed
→
Quick Reference
Check Size
$400K – $1.5M
Stages
Pre-Seed · Seed
AUM
$120M
Decision
Partnership · ~1 Month
Warm Intro
Preferred
Involvement
Board Seat
Location
San Francisco, California
Sector Focus
Manufacturing & IndustrialAerospace & DefenseBiotech & Life SciencesSemiconductors & HardwareLogistics & Supply ChainRobotics & AutomationClimate & SustainabilityDeveloper Tools & InfrastructureEnergy & Power
Models
HardwareBiotechDeep TechClimateAerospaceDefenseAdvanced Manufacturing
Technology
HardwareQuantum ComputingSynthetic BiologyAI For Drug Discovery
See all Manufacturing & Industrial investors →See all Aerospace & Defense investors →See all Biotech & Life Sciences investors →
Visit cantos.vc ↗

See how Cantos matches your startup

Get a personalized match report in minutes.

Get Your Match Report
Focus Areas
Manufacturing & IndustrialAerospace & DefenseBiotech & Life SciencesSemiconductors & HardwareLogistics & Supply ChainRobotics & AutomationClimate & SustainabilityDeveloper Tools & InfrastructureEnergy & Power

See how Cantos matches your startup

Get a personalized match report in minutes.

Get Your Match Report
Is this your firm? Claim your profile
F4 Intelligence Report · Last Researched August 23, 2026F4 Research Engine